Monday, November 04, 2019 12:48:40 PM
BOCA RATON, Fla., Nov. 4, 2019 /PRNewswire/ -- Jushi Holdings Inc. ("Jushi" or the "Company") (NEO: JUSH.B) (OTCQX: JUSHF), a globally-focused, multi-state cannabis and hemp operator, today announced that Jushi medical leadership and management will present at two upcoming conferences:
Medical Cannabiz Summit World to be held at the InterContinental Malta hotel in Malta on November 4-5, 2019. Dr. Laszlo Mechtler, FAAN, FAEN, FASN, Medical Director of Jushi, the DENT Neurologic Institute and DENT Cannabis Clinic will present, "R&D: Inspecting the Endocannabinoid and Central Nervous System," on Tuesday, November 5, 2019 at 1:30 p.m. CET.
Bryan, Garnier & Co. Cannabis Conference to be held at The May Fair hotel in London, UK on November 28, 2019. Daniel Swasbrook, President of Jushi Europe, will present at 11:00 a.m. GMT.
For more information about the conferences, or to schedule a one-on-one meeting with Jushi's medical leadership and management during these events, please contact KCSA Strategic Communications at Jushi@kcsa.com.
About Jushi Holdings Inc.
We are a globally focused cannabis and hemp company led by an industry leading management team. In the United States Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.
ALL IMO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM